D. A. Berry
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Global Cancer Incidence and Screening
Papers in
-
- Breast Cancer Treatment Studies 6
- Cancer Genomics and Diagnostics 4
- Oncology 10
- Cancer Treatment and Pharmacology 5
- HER2/EGFR in Cancer Research 4
- Co-authors
- Giovanni Parmigiani (2 shared papers)Eric P. Winer (3 shared papers)Joellen Schildkraut (1 shared paper)Julian Sanchez (1 shared paper)C. Cirrincione (4 shared papers)Tammy O. Tengs (1 shared paper)Andrew D. Seidman (2 shared papers)Clifford A. Hudis (4 shared papers)
- Journals
- Journal of Clinical Oncology (15 papers)Cancer Research (2 papers)Neuro-Oncology (1 paper)Cancer Investigation (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesItalyFrance
In The Last Decade
D. A. Berry
26 papers receiving 662 citations
Peers
Comparison fields: 5 of 57
- Cancer Research 191
- Oncology 239
- Genetics 245
- Statistics and Probability 64
- Pathology and Forensic Medicine 78
Countries citing papers authored by D. A. Berry
This map shows the geographic impact of D. A. Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. A. Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. A. Berry more than expected).
Fields of papers citing papers by D. A. Berry
This network shows the impact of papers produced by D. A. Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. A. Berry. The network helps show where D. A. Berry may publish in the future.
Co-authors
The 25 scholars most cited alongside D. A. Berry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 278 | |
| 2 | 1989 | 54 | |
| 3 | Race and survival from breast cancer: based on Cancer and Leukemia Group B trial 8541. | 1997 | 52 |
| 4 | 2004 | 49 | |
| 5 | 2002 | 47 | |
| 6 | 2007 | 35 | |
| 7 | 2013 | 31 | |
| 8 | 2009 | 29 | |
| 9 | The cost effectiveness of testing for the BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes | 2000 | 17 |
| 10 | 2003 | 16 | |
| 11 | 2009 | 14 | |
| 12 | 2010 | 13 | |
| 13 | 2004 | 11 | |
| 14 | 2005 | 11 | |
| 15 | 1987 | 8 | |
| 16 | 2011 | 6 | |
| 17 | 1990 | 5 | |
| 18 | 2007 | 5 | |
| 19 | 2004 | 4 | |
| 20 | 1987 | 3 |
About D. A. Berry
D. A. Berry is a scholar working on Cancer Research, Oncology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Genetics, having authored 27 papers that have together received 697 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (6 papers), Cancer Treatment and Pharmacology (5 papers), Cancer Genomics and Diagnostics (4 papers), HER2/EGFR in Cancer Research (4 papers), Radiomics and Machine Learning in Medical Imaging (4 papers), Advanced Breast Cancer Therapies (3 papers), Statistical Methods in Clinical Trials (3 papers) and Nausea and vomiting management (2 papers). The work is most often cited by research in Cancer Research (191 citations), Oncology (239 citations), Genetics (245 citations), Statistics and Probability (64 citations) and Pathology and Forensic Medicine (78 citations). D. A. Berry has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Giovanni Parmigiani, Eric P. Winer, Joellen Schildkraut, Julian Sanchez, C. Cirrincione, Tammy O. Tengs, Andrew D. Seidman, Clifford A. Hudis, L. G. Dressler and I. Craig Henderson. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Neuro-Oncology, Cancer Investigation and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.